TOMI Environmental Solutions, Inc. (TOMZ)

Over the past six months, several events have impacted TOMI Environmental Solutions' stock. In Q3 2025, TOMI reported a 95% sequential revenue increase, but also an operating and net loss. In November 2025, TOMI filed a $50 million Universal Shelf Registration and secured a $20 million equity line. TOMI announced purchase orders from a global biopharmaceutical company, a leading Cell and Gene Therapy manufacturer, and a research university. TOMI presented at the Sidoti Year End Investor Conference virtually on December 10-11, 2025. The share price as of December 31, 2025, was $0.78 per share, representing a decline of 23.53% from January 2, 2025.

TOMI Environmental Solutions' business model incorporates a "razor-and-blade" approach, where equipment sales are complemented by recurring sales of its BIT solution. Demand for disinfection and decontamination in the life sciences and pharmaceutical sectors often requires processes every six months. The company has noted that its pipeline year-over-year can sometimes be seasonal. The company's Q3 2025 revenue saw a significant sequential increase, but overall nine-month 2025 net sales were down from the prior year, partly attributed to customers deferring capital expenditure projects due to economic uncertainty and tariffs.

TOMI Environmental Solutions, Inc. is a U.S.-based global provider of disinfection and decontamination solutions, specializing in environmentally friendly technologies for bacteria decontamination and infectious disease control. The company operates within the Industrials sector, specifically in the Pollution & Treatment Controls industry, utilizing its Binary Ionization Technology (BIT) platform, which is utilized in its flagship SteraMist® brand of products. The company's major products and services include the SteraMist Product Line and iHP Corporate Service Decontamination. TOMI's solutions are applied across various sectors, including healthcare, pharmaceutical manufacturing, life sciences, food safety, government research, and commercial spaces.

TOMI Environmental Solutions operates both in the United States and internationally. In the third quarter of 2025, nearly 36% of its revenue was generated from international markets, a notable increase from 20% in the second quarter of 2025. The company has established long-term international partnerships in countries such as Germany, the Netherlands, and Italy.

In the past year, TOMI Environmental Solutions has maintained a positive brand reputation, primarily driven by its SteraMist technology. SteraMist® was named "Disinfection and Decontamination Products Company of the Year 2025." FDA rulings expanded the permitted use of hydrogen peroxide in food applications. The company's technology has received validations, including partnerships with the U.S. Army, demonstrating its effectiveness.

The ownership structure of TOMI Environmental Solutions is a mix of institutional, individual (insider), and retail investors. Institutional investors hold approximately 3.43% to 6.22% of the company's stock. Insiders own approximately 9.01% to 41.6% of the stock, with Dr. Halden Stuart Shane being the largest individual shareholder. Retail investors hold a substantial portion, estimated at around 79.20% to 84.77%.